Healthcare ❯ Health

Pharmaceuticals

Biotechnology Drug Development Clinical Trials Weight Loss Drugs Weight Loss Medication Procurement Generic Medicines Healthcare Companies Radiopharmaceuticals Prescription Drugs Subsidies Weight Management Vaccine Development Biopharmaceuticals Generic Drugs Gastroenterology Diagnostics Drug Regulation Companies Ophthalmology Cannabinoid Products Distribution Opiates Obesity Treatment

Biogen to Buy RayThera for Up to $1 Billion

The acquisition adds small-molecule anti-inflammatory candidates to Biogen’s pipeline with most payments tied to clinical and regulatory milestones.

Parabilis Prices Upsized IPO at $20, Raising $670 Million

Charlotte’s Web Moves to Convert BAT Debenture and Raise $10 Million

Cramer Backs Abbott’s Exact Sciences Buy, Calling It a Pivotal Diagnostics Move

Trump Quietly Pardons Rep. Harshbarger’s Husband in Health-Care Fraud Case